All New Cases & Investigations

BellRing Brands, Inc. (BRBR) Class Action Lawsuit

U.S. Securities Litigation

Leadership Deadline: March 23, 2026

BellRing Class Action Summary

Company BellRing Brands, Inc. (NYSE:BRBR)
Eligible Securities All BellRing Securities
Class Period November 19, 2024 through August 4, 2025
Allegations Overview Securities fraud relating to the drivers of BellRing’s sales growth and the impact of competition on demand for its products
BRBR Trigger Events May 6, 2025 – BellRing revealed that “several key retailers lowered their weeks of supply on hand” and “[w]e now expect Q3 sales growth of low single digits”
August 4, 2025 – BellRing narrowed its 2025 fiscal year guidance due to increased competition
BRBR Stock Impact May 6, 2025 – 19% Stock Drop
August 5, 2025 – 33% Stock Drop

BellRing Complaint Overview

Bleichmar Fonti & Auld LLP (“BFA”) has filed a securities fraud class action against BellRing Brands, Inc. (“BellRing” or the “Company”) and certain of the Company’s senior executives. The class action lawsuit asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in BellRing securities. The class action is pending in the U.S. District Court for the Southern District of New York. It is captioned Denha v. BellRing Brands, Inc., No. 1:26-cv-26-cv-00575.

If you lost money on your BellRing investment, you are encouraged to submit your information using the form on this page. You may also email adam@bfalaw.com or call 212.789.3619.

Why Is BellRing being Sued for Securities Fraud?

BellRing has been sued for securities fraud following significant stock drops resulting from potential violations of the federal securities laws. The declines in BellRing’s stock price caused significant losses to investors.

BellRing develops, markets, and sells “convenient nutrition” products such as ready-to-drink (“RTD”) protein shakes, powders, bars, and other protein enriched food products, primarily under the brand name Premier Protein. During the relevant period, Defendants represented that sales growth reflected increased end-consumer demand, attributing results to “organic growth,” “distribution gains,” “incremental promotional activity,” and “[s]trong macro tailwinds around protein” among other factors. At the same time, Defendants downplayed the impact of competition on demand, insisting BellRing was not experiencing any significant changes in competition, and that in the RTD category particularly, BellRing possessed a “competitive moat,” given that “the ready-to-drink category is just highly complex” and the products are “hard to formulate.”  

As alleged, in truth, BellRing’s reported sales during the Class Period were driven by its key customers stockpiling inventory, which concealed the erosion of the Company’s market share as competition intensified, and did not reflect increased end-consumer demand or brand momentum. Following the destocking, BellRing admitted that competitive pressures were materially weakening demand.

Why did BellRing’s Stock Drop?

On May 6, 2025, BellRing’s CFO revealed “several key retailers lowered their weeks of supply on hand, which is expected to be a mid-single-digit headwind to our third quarter growth,” adding “[w]e now expect Q3 sales growth of low single digits.” BellRing’s CEO further revealed that retailers had been “hoarding inventory to make sure they didn’t run out of stock on shelf” and “protecting themselves coming out of capacity constraints,” but since there had been “several quarters of high in-stock rates,” customers “felt comfortable about bringing [inventory] down. We thought this could happen.” 

This news caused the price of BellRing stock to drop $14.88 per share, or 19%, from a closing price of $78.43 per share on May 5, 2025, to $63.55 per share on May 6, 2025.

On August 4, 2025, after market hours, BellRing reported its 3Q 2025 financial results and “narrowed its fiscal year 2025 outlook for net sales.” Then, during the Company’s August 5, 2025 earnings call, BellRing’s CEO attributed the narrowed guidance to “several other competitors” gaining space to sell their products with a large retailer and that “it is not surprising to see new protein RTDs enter[ed]” the convenient nutrition market.

This news caused the price of BellRing stock to drop $17.46 per share, or nearly 33%, from a closing price of $53.64 per share on August 4, 2025, to $36.18 per share on August 5, 2025.

BellRing (BRBR) Stock Chart

BellRing Brands BRBR Stock Chart

NYSE online chart showing the BellRing (BRBR) stock drops following the May and August 2025 announcements.

What is the BellRing Leadership Deadline?

You may ask the Court no later than March 23, 2026, to appoint you as Lead Plaintiff through counsel of your choice.

To be a member of the Class, you need not take any action at this time. The ability to share in any potential future recovery is not dependent on serving as Lead Plaintiff.

How Do I Submit My Information?

If you lost money when BellRing securities dropped in price, you are encouraged to submit your information using the form on this page to speak with an attorney about your rights.

You can also contact:
Adam McCall
adam@bfalaw.com
212.789.3619

All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of any class action lawsuit. The firm will seek court approval for any potential fees and expenses.

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS.

BFA attorneys have been named “Elite Trial Lawyers” by the National Law Journal, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360 and “SuperLawyers” by Thomson Reuters.

BFA’s notable successes include a recovery of over $900 million in value from Tesla Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.

Attorney advertising. Past results do not guarantee future outcomes.

Frequently Asked Questions (FAQs)

The lawsuit is about BellRing’s false or misleading statements concerning the drivers of the Company’s sales growth and the impact of competition on demand for its products.  BellRing told investors its sales growth reflected increased end-consumer demand while downplaying the impact of competition on demand. In truth, temporary stockpiling of inventory by certain key customers drove the sales results, concealing that increased competition was eroding BellRing’s market share.

Contact BFA at adam@bfalaw.com or through the form on this page. There is no cost to you. We will review your information and determine whether you may be eligible to participate in the class action lawsuit.

The lawsuit is currently on behalf of investors who purchased or otherwise BellRing securities between November 19, 2024 and August 4, 2025, inclusive (the “Class Period”). However, eligibility depends on your specific circumstances, including when you bought your securities and whether you suffered losses. Submitting your information is the best way to determine if you may qualify.

No. You may be eligible to participate whether you sold or still hold your securities. What matters is that you purchased your securities during the class period and were harmed by the alleged misconduct, not whether you still own them.

No. If you’ve experienced a loss, we recommend submitting your information for review.

See additional FAQs here.

References